Exagen Inc
NASDAQ:XGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Exagen Inc
NASDAQ:XGN
|
US |
|
F
|
Fortive Corp
F:F03
|
US |
|
E
|
E-Future Co Ltd
KOSDAQ:134060
|
KR |
|
K
|
KGI Securities (Thailand) PCL
SET:KGI
|
TH |
|
C
|
China Chengtong Development Group Ltd
F:CCO
|
HK |
|
MP Materials Corp
F:55H0
|
US |
|
C
|
Chorus Ltd
OTC:CHRUF
|
NZ |
|
Banco Santander SA
F:BSD2
|
ES |
Intrinsic Value
Is XGN undervalued or overvalued?
See the intrinsic value estimate for
Exagen Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
XGN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with XGN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Exagen Does
Exagen Inc. is a medical diagnostics company that develops and sells blood tests for autoimmune diseases, especially conditions such as lupus, rheumatoid arthritis, Sjögren’s syndrome, and related disorders. Its tests help doctors determine whether a patient’s symptoms point to an autoimmune condition and, in some cases, help distinguish one disease from another when the diagnosis is unclear.
- Headquarters
- United States of America US
- Employees
- 216
- IPO date
- Sep 19, 2019
Revenue & Expenses Breakdown
Exagen Inc
Earnings Waterfall
Exagen Inc
The intrinsic value for
Exagen Inc (XGN) under the Base Case is hidden USD.
Compared with the current market price of 8.475 USD, the stock appears hidden.